Get started
Author

Guillaume Mahay

IL-17 in Severe Asthma. Where Do We Stand?
2014 · Julie Chesné, Faouzi Braza, et al. · American Journal of Respiratory and Critical Care Medicine · 377
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
2020 · Tim W Harrison, Pascal Chanez, et al. · The Lancet Respiratory Medicine · 175
Effectiveness and safety of dupilumab for the treatment of severe asthma in a real‐life French multi‐centre adult cohort
2020 · Clairelyne Dupin, Drifa Belhadi, et al. · Clinical & Experimental Allergy · 136
A regulatory CD9+B-cell subset inhibits HDM-induced allergic airway inflammation
2015 · F. Braza, J. Chesne, et al. · Allergy · 78
Prime role of IL-17A in neutrophilia and airway smooth muscle contraction in a house dust mite–induced allergic asthma model
2015 · Julie Chesné, Faouzi Braza, et al. · Journal of Allergy and Clinical Immunology · 67
PDF
Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study
2022 · Rod Hughes, Eleni Rapsomaniki, et al. · Respiratory Medicine · 47
PDF
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
2023 · Renaud Louis, Tim W. Harrison, et al. · The Journal of Allergy and Clinical Immunology In Practice · 26
PDF
Food allergy enhances allergic asthma in mice
2014 · Tiphaine Bihouée, Gregory Bouchaud, et al. · Respiratory Research · 26
PDF
Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD
2023 · Erin L. Tomaszewski, Mark J. Atkinson, et al. · Respiratory Research · 25
PDF
The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study
2022 · Sarowar Muhammad Golam, Christer Janson, et al. · Respiratory Medicine · 20
PDF
Medical algorithm: Aspergillus fumigatus components in the diagnosis of allergic bronchopulmonary aspergillosis
2021 · Raphael Lukaszewicz, Guillaume Mahay, et al. · Allergy · 16
Impact of pharmacological and non-pharmacological interventions on mortality in chronic obstructive pulmonary disease (COPD) patients
2023 · Maeva Zysman, Guillaume Mahay, et al. · Respiratory Medicine and Research · 13
Block Copolymer/DNA Vaccination Induces a Strong Allergen-Specific Local Response in a Mouse Model of House Dust Mite Asthma
2014 · Camille Rolland-Debord, David Lair, et al. · PLoS ONE · 13
PDF
Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers
2023 · Bo Ding, Stephanie Chen, et al. · The Journal of Allergy and Clinical Immunology In Practice · 10
PDF
Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum
2023 · Rod Hughes, Eleni Rapsomaniki, et al. · The Journal of Allergy and Clinical Immunology In Practice · 10
PDF
Long-acting muscarinic antagonists (LAMA) in asthma: What is the best strategy?
2025 · Guillaume Mahay, Maeva Zysman, et al. · Respiratory Medicine and Research · 6
Les exacerbations d’asthme chez l’adulte : prévenir et guérir
2019 · Guillaume Mahay, Mathilde Le Brun, et al. · La Presse Médicale · 5
PDF
Évaluation multicentrique et randomisée de l’impact des conseillers en environnement intérieur sur le contrôle de l’asthme : l’étude ECENVIR
2022 · J.P. Gangneux, H. Morel, et al. · Revue française d'allergologie · 4
Long-term effectiveness and safety of dupilumab in severe asthma: A 5-year real-world multicenter study
2025 · Astrid Chauvin, Drifa Belhadi, et al. · The Journal of Allergy and Clinical Immunology In Practice · 2
Marqueurs de sévérité et marqueurs prédictifs de réponse au traitement dans l’asthme sévère
2022 · L. Sesé, G. Mahay, et al. · Revue des Maladies Respiratoires · 1
Dupilumab in Severe Asthma: A Real-Life Cohort in France
2019 · C. Dupin, L. Guilleminault, et al. · 1
Transcutaneous sensitization induces IL-17-mediated airway hyperresponsiveness in a house dust mite-induced model of asthma
2014 · J. Chesne, F. Braza, et al. · Revue des Maladies Respiratoires · 1
Facteurs de risque de complications de l’immunothérapie au venin d’hyménoptère chez l’enfant : résultats d’une cohorte rétrospective multicentrique
2025 · N. Worbe, A. Teboul, et al. · Revue française d'allergologie
Au-delà de l’abeille : l’allergie méconnue au bourdon
2025 · M. Quatremare, M. Carrette, et al. · Revue française d'allergologie
L’intérêt des IgE dirigées contre les antigènes recombinants d’Aspergillus fumigatus dans le diagnostic de l’ABPA chez les patients atteints de BPCO, une étude prospective monocentrique
2025 · C. Farhi, J. Martinet, et al. · Revue des Maladies Respiratoires Actualités
Works count: 53
Citation count: 1,059
H-index: 13
I10-index: 15
Year
Topic
Type